They Hybrimune Hybridoma Production System was developed for large volume commercial applications using cell electrofusion. This includes hybridoma production and tumor/dendritic cell immunotherapy. The system has not been approved for clinical or in vitro diagnostic use. The system can fuse up to 180 million cells in one process run.